Guasparini R - Search Results

1

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus.

Patrick DM, Petric M, Skowronski DM, Guasparini R, Booth TF, Krajden M, McGeer P, Bastien N, Gustafson L, Dubord J, Macdonald D, David ST, Srour LF, Parker R, Andonov A, Isaac-Renton J, Loewen N, McNabb G, McNabb A, Goh SH, Henwick S, Astell C, Guo JP, Drebot M, Tellier R, Plummer F, Brunham RC. Patrick DM, et al. Among authors: guasparini r. Can J Infect Dis Med Microbiol. 2006 Nov;17(6):330-6. doi: 10.1155/2006/152612. Can J Infect Dis Med Microbiol. 2006. PMID: 18382647 Free PMC article.

2

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.

Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L. Halperin SA, et al. Among authors: guasparini r. Vaccine. 2000 Jan 31;18(14):1312-9. doi: 10.1016/s0264-410x(99)00415-6. Vaccine. 2000. PMID: 10618527 Clinical Trial.

3

Evaluation of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) in Canadian infants.

Scheifele DW, Bjornson GL, Meekison WG, Guasparini R, Mitchell LA. Scheifele DW, et al. Among authors: guasparini r. Can J Infect Dis. 1994 Mar;5(2):75-81. doi: 10.1155/1994/479313. Can J Infect Dis. 1994. PMID: 22451769 Free PMC article.

4

Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age.

Gold R, Barreto L, Ferro S, Thippawong J, Guasparini R, Meekison W, Russell M, Mills E, Harrison D, Lavigne P. Gold R, et al. Among authors: guasparini r. Can J Infect Dis Med Microbiol. 2007 Jul;18(4):241-8. doi: 10.1155/2007/289842. Can J Infect Dis Med Microbiol. 2007. PMID: 18923741 Free PMC article.

5

Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?

Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Scheifele D, et al. Among authors: guasparini r. CMAJ. 1993 Oct 15;149(8):1105-12. CMAJ. 1993. PMID: 8221449 Free PMC article. Clinical Trial.

6

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B. Halperin SA, et al. Among authors: guasparini r. Vaccine. 2003 Jun 2;21(19-20):2298-306. doi: 10.1016/s0264-410x(03)00173-7. Vaccine. 2003. PMID: 12744860 Clinical Trial.

7

Controlled trial of Haemophilus influenzae type B diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection.

Scheifele D, Bjornson G, Barreto L, Meekison W, Guasparini R. Scheifele D, et al. Among authors: guasparini r. Vaccine. 1992;10(7):455-60. doi: 10.1016/0264-410x(92)90394-y. Vaccine. 1992. PMID: 1609548 Clinical Trial.

8

Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children.

Scheifele DW, Meekison W, Guasparini R, Roberts A, Barreto L, Thipphawong J, Wiltsey S. Scheifele DW, et al. Among authors: guasparini r. Vaccine. 1995 Jan;13(1):104-8. doi: 10.1016/0264-410x(95)80019-a. Vaccine. 1995. PMID: 7762265 Clinical Trial.

9

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R, et al. Halperin SA, et al. Among authors: guasparini r. Scand J Infect Dis. 1995;27(3):279-87. doi: 10.3109/00365549509019022. Scand J Infect Dis. 1995. PMID: 8539554 Clinical Trial.

10

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

Halperin SA, Eastwood BJ, Barreto L, Friesen B, Medd L, Meekison W, Guasparini R. Halperin SA, et al. Among authors: guasparini r. Vaccine. 1996 Jun;14(8):767-72. doi: 10.1016/0264-410x(95)00250-5. Vaccine. 1996. PMID: 8817823 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page